Retatrutide
Price on application
Retatrutide (LY3437943) is a cutting-edge, unimolecular triple receptor agonist. It targets the GLP-1, GIP, and glucagon (GCG) receptors, offering unprecedented potential in research involving weight management and metabolic health.
Research Profile
Retatrutide represents the latest frontier in incretin-based research. Unlike previous dual-agonists, Retatrutide incorporates a third mechanism by activating the glucagon receptor. This "triple-threat" approach aims to optimize energy expenditure while simultaneously regulating glucose and appetite. By mimicking three different hormones, Retatrutide offers a synergistic effect: GIP improves insulin sensitivity, GLP-1 slows gastric emptying and suppresses appetite, and Glucagon increases metabolic rate and thermogenesis. This comprehensive profile makes it a primary subject for studies on obesity, Type 2 Diabetes, and NAFLD (Non-Alcoholic Fatty Liver Disease).
Technical Details
- Chemical Formula
- C221H342N52O68
- Synonyms
- LY3437943, Triple Agonist GGG
- Molecular Weight
- 4731.33 g/mol
- CAS Number
- 2381089-83-2
- Appearance
- Lyophilized White Powder
- Purity
- >99% (HPLC/MS Verified)
- Solubility
- Water / Bacterostatic Water
- Shelf Life
- 36 months (Store at -20°C)